TECH BIO-TECHNE CORP revenue, earnings and financials

For the quarter ended March 31, 2026, BIO-TECHNE CORP reported revenue of $311M (down 1.5% from a year earlier), net income of $51.0M and diluted EPS of $0.32; over the last four quarters revenue was $1.21B and net income $110M; for the fiscal year ended June 2025 revenue was $1.22B, up 5.2% on the year before.

TECH annual revenue and earnings

• Fiscal year ended Jun 2025: revenue $1.22B, gross profit $790M, operating income $102M, net income $73.4M (margin 6.0%), EPS $0.46
• Fiscal year ended Jun 2024: revenue $1.16B, gross profit $770M, operating income $207M, net income $168M (margin 14.5%), EPS $1.05
• Fiscal year ended Jun 2023: revenue $1.14B, gross profit $770M, operating income $299M, net income $285M (margin 25.1%), EPS $1.76
• Fiscal year ended Jun 2022: revenue $1.11B, gross profit $756M, operating income $297M, net income $272M (margin 24.6%), EPS $1.66
• Fiscal year ended Jun 2021: revenue $931M, gross profit $633M, operating income $237M, net income $140M (margin 15.1%), EPS $0.87

TECH quarterly revenue and earnings

• Quarter ended Mar 31, 2026: revenue $311M (down 1.5% year over year), net income $51.0M, EPS $0.32
• Quarter ended Dec 31, 2025: revenue $296M (down 0.4% year over year), net income $38.0M, EPS $0.24
• Quarter ended Sep 30, 2025: revenue $287M (down 1.0% year over year), net income $38.2M, EPS $0.24
• Quarter ended Jun 30, 2025 (from the annual report): revenue $317M (up 3.5% year over year), net income −$17.7M, EPS −$0.11
• Quarter ended Mar 31, 2025: revenue $316M (up 4.2% year over year), net income $22.6M, EPS $0.14
• Quarter ended Dec 31, 2024: revenue $297M (up 9.0% year over year), net income $34.9M, EPS $0.22
• Quarter ended Sep 30, 2024: revenue $289M (up 4.5% year over year), net income $33.6M, EPS $0.21
• Quarter ended Jun 30, 2024 (from the annual report): revenue $306M (up 1.6% year over year), net income $40.6M, EPS $0.26
• Quarter ended Mar 31, 2024: revenue $303M (up 3.2% year over year), net income $49.1M, EPS $0.31
• Quarter ended Dec 31, 2023: revenue $273M (up 0.4% year over year), net income $27.5M, EPS $0.17
• Quarter ended Sep 30, 2023: revenue $277M (up 2.7% year over year), net income $51.0M, EPS $0.31
• Quarter ended Jun 30, 2023 (from the annual report): revenue $301M (up 4.5% year over year), net income $75.5M, EPS $0.47
• Quarter ended Mar 31, 2023: revenue $294M (up 1.3% year over year), net income $70.2M, EPS $0.43
• Quarter ended Dec 31, 2022: revenue $272M (up 0.9% year over year), net income $50.0M, EPS $0.31
• Quarter ended Sep 30, 2022: revenue $270M (up 4.6% year over year), net income $89.6M, EPS $0.55
• Quarter ended Jun 30, 2022 (from the annual report): revenue $288M, net income $61.5M, EPS −$0.89
• Quarter ended Mar 31, 2022: revenue $290M (up 19.2% year over year), net income $60.7M, EPS $0.37
• Quarter ended Dec 31, 2021: revenue $269M, net income $80.2M, EPS $0.49
• Quarter ended Sep 30, 2021: revenue $258M, net income $69.6M, EPS $1.69
• Quarter ended Mar 31, 2021: revenue $244M, net income $45.8M, EPS $1.12

TECH cash flow, buybacks and dividends

• Fiscal year ended Jun 2025: operating cash flow $288M, share buybacks $276M, dividends $0.32 per share
• Fiscal year ended Jun 2024: operating cash flow $299M, share buybacks $80.0M, dividends $0.32 per share
• Fiscal year ended Jun 2023: operating cash flow $254M, share buybacks $19.6M, dividends $0.32 per share
• Fiscal year ended Jun 2022: operating cash flow $325M, share buybacks $161M, dividends $0.32 per share
• Fiscal year ended Jun 2021: operating cash flow $352M, share buybacks $43.2M, dividends $0.32 per share

TECH balance sheet

• Jun 30, 2026: cash $265M, total assets $2.59B, total liabilities n/a, shareholders' equity $2.11B
• Mar 31, 2026: cash $210M, total assets $2.55B, total liabilities n/a, shareholders' equity $2.09B
• Dec 31, 2025: cash $173M, total assets $2.52B, total liabilities n/a, shareholders' equity $2.01B
• Sep 30, 2025: cash $145M, total assets $2.53B, total liabilities n/a, shareholders' equity n/a
• Jun 30, 2025: cash $162M, total assets $2.56B, total liabilities n/a, shareholders' equity $1.92B
• Mar 31, 2025: cash $141M, total assets $2.64B, total liabilities n/a, shareholders' equity $2.02B
• Dec 31, 2024: cash $178M, total assets $2.67B, total liabilities n/a, shareholders' equity $2.08B
• Sep 30, 2024: cash $188M, total assets $2.74B, total liabilities n/a, shareholders' equity $2.14B

What is TECH's revenue?

BIO-TECHNE CORP reported $1.21B of revenue over its last four quarters, through March 31, 2026.

Is TECH profitable?

Yes. BIO-TECHNE CORP earned $110M over the last four quarters.

What is TECH's EPS?

Diluted earnings per share over the last four quarters were $0.69; $0.32 in the latest quarter.

Does TECH pay a dividend?

BIO-TECHNE CORP paid $0.32 per share in dividends in the fiscal year ended June 2025.

TECH ownership and insider trades · All stocks